| scholarly article | Q13442814 |
| P50 | author | Xia Ningshao | Q57869616 |
| Shaowei Li | Q90605940 | ||
| P2093 | author name string | Jun Zhang | |
| Ying Gu | |||
| Xiao Zhang | |||
| Chunyan Yang | |||
| Hailian Du | |||
| Nan Wang | |||
| Minxi Wei | |||
| Huirong Pan | |||
| P2860 | cites work | The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli | Q46795652 |
| A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. | Q51525883 | ||
| Hepatitis E virus. | Q53862581 | ||
| [Construction and application of an Escherichia coli high effective expression vector with an enhancer] | Q54020652 | ||
| Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding | Q24655874 | ||
| Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure | Q27646563 | ||
| Dimerization of Hepatitis E Virus Capsid Protein E2s Domain Is Essential for Virus–Host Interaction | Q27656916 | ||
| Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling | Q27860847 | ||
| Understanding the mechanism of beta-sheet folding from a chemical and biological perspective | Q28296428 | ||
| Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques | Q30447247 | ||
| Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome | Q33415661 | ||
| Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route | Q34055652 | ||
| Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway | Q34236742 | ||
| A hydrophobic heptad repeat of the core protein of woodchuck hepatitis virus is required for capsid assembly | Q35870788 | ||
| Expression and self-assembly of empty virus-like particles of hepatitis E virus | Q35894748 | ||
| Beta-sheet folding mechanisms from perturbation energetics | Q36379845 | ||
| An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity | Q36525404 | ||
| Hepatitis E: an emerging awareness of an old disease | Q37055890 | ||
| Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells | Q37132094 | ||
| Putative receptor-binding sites of hepatitis E virus. | Q40033753 | ||
| ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates | Q41537344 | ||
| Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes | Q41632254 | ||
| Equilibrium dissociation and unfolding of the dimeric human papillomavirus strain-16 E2 DNA-binding domain | Q42078440 | ||
| Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. | Q42470891 | ||
| Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates | Q43410896 | ||
| Mutation of interfacial residues disrupts subunit folding and particle assembly of Physalis mottle tymovirus | Q44246045 | ||
| Viral hepatitis during pregnancy | Q44385127 | ||
| Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial | Q45189946 | ||
| Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein | Q45737295 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis E | Q326643 |
| hepatitis E virus | Q5731737 | ||
| P304 | page(s) | 314-326 | |
| P577 | publication date | 2013-01-17 | |
| P1433 | published in | Protein Science | Q7251445 |
| P1476 | title | Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts | |
| P478 | volume | 22 |
| Q40585281 | A shared N-terminal hydrophobic tail for the formation of nanoparticulates |
| Q40111455 | Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine. |
| Q51733616 | Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro. |
| Q47132009 | Escherichia coli-derived virus-like particles in vaccine development |
| Q37375936 | Hepatitis E virus: Current epidemiology and vaccine |
| Q42228306 | Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles |
| Q27013018 | Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins |
| Q40507392 | Prophylactic Hepatitis E Vaccine |
| Q38699244 | Prophylaxis against hepatitis E: at risk populations and human vaccines. |
| Q42212470 | Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®). |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q34464464 | The development of a recombinant hepatitis E vaccine HEV 239. |
Search more.